BRCA1 mutations are most commonly associated with triple-negative breast cancer (TNBC), a subtype lacking the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene BRCA1 and triple-negative breast carcinoma.